Educational guide for research and informational purposes only. Not medical advice.
The GLOW and KLOW blends represent a comprehensive approach to recovery beyond simple injury repair — designed for the person who wants tissue repair, skin quality, gut protection, and anti-inflammatory coverage in a single pre-blended vial.
GLOW: BPC-157 + GHK-Cu + TB-500
GLOW (BPC-157 / GHK-Cu / TB-500) 10mg/50mg/10mg — Lyophilized
| Compound | Dose | Primary Role |
|---|---|---|
| BPC-157 | 10mg | Vascularization, fibroblast activation, gut healing |
| GHK-Cu | 50mg | Collagen synthesis, skin quality, antioxidant gene activation |
| TB-500 | 10mg | Systemic anti-inflammation, cell migration, tissue remodeling |
The Wolverine blend (BPC-157 + TB-500) covers tissue repair comprehensively. GLOW extends this with GHK-Cu — which targets collagen quality, skin architecture, and oxidative damage in connective tissue. GHK-Cu directly stimulates collagen synthesis in the dermis (relevant for skin elasticity after weight changes), activates matrix metalloproteinases that remodel scar tissue, and provides antioxidant activity protecting against UV-induced and metabolic oxidative damage.
KLOW: BPC-157 + GHK-Cu + TB-500 + KPV
KLOW (BPC-157 / GHK-Cu / TB-500 / KPV) 10mg/50mg/10mg/10mg — Lyophilized
| Compound | Dose | Primary Role |
|---|---|---|
| BPC-157 | 10mg | Vascularization, fibroblast activation, gut healing |
| GHK-Cu | 50mg | Collagen synthesis, skin quality, antioxidant gene activation |
| TB-500 | 10mg | Systemic anti-inflammation, cell migration, tissue remodeling |
| KPV | 10mg | NF-kB inhibition, gut mucosal protection, wound healing |
KLOW adds KPV — a tripeptide (the C-terminal fragment of alpha-MSH). KPV mechanisms include direct anti-inflammatory activity (reduces NF-kB, IL-6, TNF-α, IL-1β), gut mucosal protection with significant evidence against colitis and intestinal inflammation, wound healing via melanocortin receptor activation, and skin anti-inflammatory effects.
GLOW vs KLOW: Which to Choose
| Goal | GLOW | KLOW |
|---|---|---|
| Tissue repair + skin quality | ✓ | ✓ |
| GI inflammation / leaky gut / IBD | — | ✓ (KPV) |
| Running GLP-1 therapy (GI management) | — | ✓ (KPV) |
| Systemic inflammation priority | — | ✓ (KPV) |
| Post-surgical / injury recovery | ✓ | ✓ |
| Skin quality during weight loss | ✓ | ✓ |
Choose GLOW when recovery and skin quality are the primary goals and GI health is not a specific concern.
Choose KLOW when GI inflammation is present, systemic inflammation is elevated, or you're running GLP-1 therapy and want KPV's gut-protective activity alongside the blend.
The Women's Performance Recovery Stack
For women focused on body recomposition — particularly those running GLP-1 therapy:
- Tirzepatide + B12 (34mg/2mg) or Semaglutide + B12 — fat loss foundation
- GLOW or KLOW — skin quality, connective tissue, recovery, and inflammation
- CJC-1295 / Ipamorelin — lean mass preservation via GH axis support
The logic: GLP-1 creates the caloric deficit. CJC-1295/Ipamorelin preserves lean mass. GLOW/KLOW protects skin quality, connective tissue, and recovery capacity throughout rapid body composition change.
For women on HRT: Signature HRT Membership (Female) + Hormone Specific Female Panel
Reconstitution
Both GLOW and KLOW come lyophilized. Add 2mL Bacteriostatic Water. SC injection, abdomen preferred. Store reconstituted at 2–8°C, use within 28 days. Protect from light.
Supplies: Complete Injection Kit
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018.
- Chang CH, et al. Pentadecapeptide BPC 157 promotes tendon healing. J Appl Physiol. 2011.
- Catania A, et al. The melanocortin system in control of inflammation. Sci World J. 2010.
- Huang JL, et al. Anti-inflammatory effects of alpha-MSH peptide fragments KPV in colitis. Gut. 2002.
Educational Disclaimer: For educational and informational purposes only. Not medical advice. Consult a qualified healthcare provider.
